The global market for Biobetter was estimated to be worth US$ 832 million in 2023 and is forecast to a readjusted size of US$ 1538 million by 2030 with a CAGR of 9.1% during the forecast period 2024-2030

Biobetter - Market

Biobetters, also known as biosuperiors, are recombinant protein drugs from an identical class as a present set of biopharmaceuticals is not similar to the source. It is neither a wholly novel medicine nor a generic version of an old drug. It is a biological product designed to increase clinical efficacy while also improving tolerance and lowering dosing/administration frequency.

According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biobetter, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Biobetter by region & country, by Type, and by Application.

The Biobetter market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biobetter.

Market Segmentation

Scope of Biobetter - Market Report

Report Metric	Details
Report Name	Biobetter - Market
Forecasted market size in 2030	US$ 1538 million
CAGR	9.1%
Forecasted years	2024 - 2030
Segment by Type:	G-CSF Biobetters Insulin Biobetters Erythropoietin Biobetters Monoclonal Antibodies Biobetters Others
Segment by Application	Cancer Diabetes Genetic Disease Neurological Disorders Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	F.Hoffmann-La Roche AG, Merck and Co., Sanofi, SERVIER, Porton Biopharma, Eli Lily and Company, Novo Nordisk, Biogen, CSL Behring GmbH, Teva
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Biobetter manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Biobetter in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Biobetter in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Biobetter - Market size in 2030?

Ans: The Biobetter - Market size in 2030 will be US$ 1538 million.

Who are the main players in the Biobetter - Market report?

Ans: The main players in the Biobetter - Market are F.Hoffmann-La Roche AG, Merck and Co., Sanofi, SERVIER, Porton Biopharma, Eli Lily and Company, Novo Nordisk, Biogen, CSL Behring GmbH, Teva

What are the Application segmentation covered in the Biobetter - Market report?

Ans: The Applications covered in the Biobetter - Market report are Cancer, Diabetes, Genetic Disease, Neurological Disorders, Others

What are the Type segmentation covered in the Biobetter - Market report?

Ans: The Types covered in the Biobetter - Market report are G-CSF Biobetters, Insulin Biobetters, Erythropoietin Biobetters, Monoclonal Antibodies Biobetters, Others

1 Market Overview

1.1 Biobetter Product Introduction

1.2 Global Biobetter Market Size Forecast

1.2.1 Global Biobetter Sales Value (2019-2030)

1.2.2 Global Biobetter Sales Volume (2019-2030)

1.2.3 Global Biobetter Sales Price (2019-2030)

1.3 Biobetter Market Trends & Drivers

1.3.1 Biobetter Industry Trends

1.3.2 Biobetter Market Drivers & Opportunity

1.3.3 Biobetter Market Challenges

1.3.4 Biobetter Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Biobetter Players Revenue Ranking (2023)

2.2 Global Biobetter Revenue by Company (2019-2024)

2.3 Global Biobetter Players Sales Volume Ranking (2023)

2.4 Global Biobetter Sales Volume by Company Players (2019-2024)

2.5 Global Biobetter Average Price by Company (2019-2024)

2.6 Key Manufacturers Biobetter Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Biobetter Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Biobetter

2.9 Biobetter Market Competitive Analysis

2.9.1 Biobetter Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Biobetter Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biobetter as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 G-CSF Biobetters

3.1.2 Insulin Biobetters

3.1.3 Erythropoietin Biobetters

3.1.4 Monoclonal Antibodies Biobetters

3.1.5 Others

3.2 Global Biobetter Sales Value by Type

3.2.1 Global Biobetter Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Biobetter Sales Value, by Type (2019-2030)

3.2.3 Global Biobetter Sales Value, by Type (%) (2019-2030)

3.3 Global Biobetter Sales Volume by Type

3.3.1 Global Biobetter Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Biobetter Sales Volume, by Type (2019-2030)

3.3.3 Global Biobetter Sales Volume, by Type (%) (2019-2030)

3.4 Global Biobetter Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Cancer

4.1.2 Diabetes

4.1.3 Genetic Disease

4.1.4 Neurological Disorders

4.1.5 Others

4.2 Global Biobetter Sales Value by Application

4.2.1 Global Biobetter Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Biobetter Sales Value, by Application (2019-2030)

4.2.3 Global Biobetter Sales Value, by Application (%) (2019-2030)

4.3 Global Biobetter Sales Volume by Application

4.3.1 Global Biobetter Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Biobetter Sales Volume, by Application (2019-2030)

4.3.3 Global Biobetter Sales Volume, by Application (%) (2019-2030)

4.4 Global Biobetter Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Biobetter Sales Value by Region

5.1.1 Global Biobetter Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Biobetter Sales Value by Region (2019-2024)

5.1.3 Global Biobetter Sales Value by Region (2025-2030)

5.1.4 Global Biobetter Sales Value by Region (%), (2019-2030)

5.2 Global Biobetter Sales Volume by Region

5.2.1 Global Biobetter Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Biobetter Sales Volume by Region (2019-2024)

5.2.3 Global Biobetter Sales Volume by Region (2025-2030)

5.2.4 Global Biobetter Sales Volume by Region (%), (2019-2030)

5.3 Global Biobetter Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Biobetter Sales Value, 2019-2030

5.4.2 North America Biobetter Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Biobetter Sales Value, 2019-2030

5.5.2 Europe Biobetter Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Biobetter Sales Value, 2019-2030

5.6.2 Asia Pacific Biobetter Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Biobetter Sales Value, 2019-2030

5.7.2 South America Biobetter Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Biobetter Sales Value, 2019-2030

5.8.2 Middle East & Africa Biobetter Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Biobetter Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Biobetter Sales Value

6.2.1 Key Countries/Regions Biobetter Sales Value, 2019-2030

6.2.2 Key Countries/Regions Biobetter Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Biobetter Sales Value, 2019-2030

6.3.2 United States Biobetter Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Biobetter Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Biobetter Sales Value, 2019-2030

6.4.2 Europe Biobetter Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Biobetter Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Biobetter Sales Value, 2019-2030

6.5.2 China Biobetter Sales Value by Type (%), 2023 VS 2030

6.5.3 China Biobetter Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Biobetter Sales Value, 2019-2030

6.6.2 Japan Biobetter Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Biobetter Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Biobetter Sales Value, 2019-2030

6.7.2 South Korea Biobetter Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Biobetter Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Biobetter Sales Value, 2019-2030

6.8.2 Southeast Asia Biobetter Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Biobetter Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Biobetter Sales Value, 2019-2030

6.9.2 India Biobetter Sales Value by Type (%), 2023 VS 2030

6.9.3 India Biobetter Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 F.Hoffmann-La Roche AG

7.1.1 F.Hoffmann-La Roche AG Company Information

7.1.2 F.Hoffmann-La Roche AG Introduction and Business Overview

7.1.3 F.Hoffmann-La Roche AG Biobetter Sales, Revenue and Gross Margin (2019-2024)

7.1.4 F.Hoffmann-La Roche AG Biobetter Product Offerings

7.1.5 F.Hoffmann-La Roche AG Recent Development

7.2 Merck and Co.

7.2.1 Merck and Co. Company Information

7.2.2 Merck and Co. Introduction and Business Overview

7.2.3 Merck and Co. Biobetter Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Merck and Co. Biobetter Product Offerings

7.2.5 Merck and Co. Recent Development

7.3 Sanofi

7.3.1 Sanofi Company Information

7.3.2 Sanofi Introduction and Business Overview

7.3.3 Sanofi Biobetter Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Sanofi Biobetter Product Offerings

7.3.5 Sanofi Recent Development

7.4 SERVIER

7.4.1 SERVIER Company Information

7.4.2 SERVIER Introduction and Business Overview

7.4.3 SERVIER Biobetter Sales, Revenue and Gross Margin (2019-2024)

7.4.4 SERVIER Biobetter Product Offerings

7.4.5 SERVIER Recent Development

7.5 Porton Biopharma

7.5.1 Porton Biopharma Company Information

7.5.2 Porton Biopharma Introduction and Business Overview

7.5.3 Porton Biopharma Biobetter Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Porton Biopharma Biobetter Product Offerings

7.5.5 Porton Biopharma Recent Development

7.6 Eli Lily and Company

7.6.1 Eli Lily and Company Company Information

7.6.2 Eli Lily and Company Introduction and Business Overview

7.6.3 Eli Lily and Company Biobetter Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Eli Lily and Company Biobetter Product Offerings

7.6.5 Eli Lily and Company Recent Development

7.7 Novo Nordisk

7.7.1 Novo Nordisk Company Information

7.7.2 Novo Nordisk Introduction and Business Overview

7.7.3 Novo Nordisk Biobetter Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Novo Nordisk Biobetter Product Offerings

7.7.5 Novo Nordisk Recent Development

7.8 Biogen

7.8.1 Biogen Company Information

7.8.2 Biogen Introduction and Business Overview

7.8.3 Biogen Biobetter Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Biogen Biobetter Product Offerings

7.8.5 Biogen Recent Development

7.9 CSL Behring GmbH

7.9.1 CSL Behring GmbH Company Information

7.9.2 CSL Behring GmbH Introduction and Business Overview

7.9.3 CSL Behring GmbH Biobetter Sales, Revenue and Gross Margin (2019-2024)

7.9.4 CSL Behring GmbH Biobetter Product Offerings

7.9.5 CSL Behring GmbH Recent Development

7.10 Teva

7.10.1 Teva Company Information

7.10.2 Teva Introduction and Business Overview

7.10.3 Teva Biobetter Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Teva Biobetter Product Offerings

7.10.5 Teva Recent Development

8 Industry Chain Analysis

8.1 Biobetter Industrial Chain

8.2 Biobetter Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Biobetter Sales Model

8.5.2 Sales Channel

8.5.3 Biobetter Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

F. Hoffmann-La Roche AG

List of Tables

Table 1. Biobetter Market Trends

Table 2. Biobetter Market Drivers & Opportunity

Table 3. Biobetter Market Challenges

Table 4. Biobetter Market Restraints

Table 5. Global Biobetter Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Biobetter Revenue Market Share by Company (2019-2024)

Table 7. Global Biobetter Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Biobetter Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Biobetter Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Biobetter Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Biobetter Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Biobetter

Table 13. Global Biobetter Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biobetter as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Biobetter Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Biobetter Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Biobetter Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Biobetter Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Biobetter Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Biobetter Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Biobetter Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Biobetter Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Biobetter Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Biobetter Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Biobetter Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Biobetter Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Biobetter Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Biobetter Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Biobetter Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Biobetter Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Biobetter Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Biobetter Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Biobetter Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Biobetter Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Biobetter Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Biobetter Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Biobetter Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Biobetter Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Biobetter Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Biobetter Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Biobetter Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Biobetter Sales Value by Region (2019-2024) & (%)

Table 44. Global Biobetter Sales Value by Region (2025-2030) & (%)

Table 45. Global Biobetter Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Biobetter Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Biobetter Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Biobetter Sales Volume by Region (2019-2024) & (%)

Table 49. Global Biobetter Sales Volume by Region (2025-2030) & (%)

Table 50. Global Biobetter Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Biobetter Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Biobetter Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Biobetter Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Biobetter Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Biobetter Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Biobetter Sales Volume, (2025-2030) & (K Units)

Table 57. F.Hoffmann-La Roche AG Company Information

Table 58. F.Hoffmann-La Roche AG Introduction and Business Overview

Table 59. F.Hoffmann-La Roche AG Biobetter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. F.Hoffmann-La Roche AG Biobetter Product Offerings

Table 61. F.Hoffmann-La Roche AG Recent Development

Table 62. Merck and Co. Company Information

Table 63. Merck and Co. Introduction and Business Overview

Table 64. Merck and Co. Biobetter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Merck and Co. Biobetter Product Offerings

Table 66. Merck and Co. Recent Development

Table 67. Sanofi Company Information

Table 68. Sanofi Introduction and Business Overview

Table 69. Sanofi Biobetter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Sanofi Biobetter Product Offerings

Table 71. Sanofi Recent Development

Table 72. SERVIER Company Information

Table 73. SERVIER Introduction and Business Overview

Table 74. SERVIER Biobetter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. SERVIER Biobetter Product Offerings

Table 76. SERVIER Recent Development

Table 77. Porton Biopharma Company Information

Table 78. Porton Biopharma Introduction and Business Overview

Table 79. Porton Biopharma Biobetter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Porton Biopharma Biobetter Product Offerings

Table 81. Porton Biopharma Recent Development

Table 82. Eli Lily and Company Company Information

Table 83. Eli Lily and Company Introduction and Business Overview

Table 84. Eli Lily and Company Biobetter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Eli Lily and Company Biobetter Product Offerings

Table 86. Eli Lily and Company Recent Development

Table 87. Novo Nordisk Company Information

Table 88. Novo Nordisk Introduction and Business Overview

Table 89. Novo Nordisk Biobetter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Novo Nordisk Biobetter Product Offerings

Table 91. Novo Nordisk Recent Development

Table 92. Biogen Company Information

Table 93. Biogen Introduction and Business Overview

Table 94. Biogen Biobetter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Biogen Biobetter Product Offerings

Table 96. Biogen Recent Development

Table 97. CSL Behring GmbH Company Information

Table 98. CSL Behring GmbH Introduction and Business Overview

Table 99. CSL Behring GmbH Biobetter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. CSL Behring GmbH Biobetter Product Offerings

Table 101. CSL Behring GmbH Recent Development

Table 102. Teva Company Information

Table 103. Teva Introduction and Business Overview

Table 104. Teva Biobetter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Teva Biobetter Product Offerings

Table 106. Teva Recent Development

Table 107. Key Raw Materials Lists

Table 108. Raw Materials Key Suppliers Lists

Table 109. Biobetter Downstream Customers

Table 110. Biobetter Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Biobetter Product Picture

Figure 2. Global Biobetter Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Biobetter Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Biobetter Sales Volume (2019-2030) & (K Units)

Figure 5. Global Biobetter Sales Price (2019-2030) & (US$/Unit)

Figure 6. Biobetter Report Years Considered

Figure 7. Global Biobetter Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Biobetter Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Biobetter Revenue in 2023

Figure 10. Biobetter Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. G-CSF Biobetters Picture

Figure 12. Insulin Biobetters Picture

Figure 13. Erythropoietin Biobetters Picture

Figure 14. Monoclonal Antibodies Biobetters Picture

Figure 15. Others Picture

Figure 16. Global Biobetter Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Biobetter Sales Value Market Share by Type, 2023 & 2030

Figure 18. Global Biobetter Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 19. Global Biobetter Sales Volume Market Share by Type, 2023 & 2030

Figure 20. Global Biobetter Price by Type (2019-2030) & (US$/Unit)

Figure 21. Product Picture of Cancer

Figure 22. Product Picture of Diabetes

Figure 23. Product Picture of Genetic Disease

Figure 24. Product Picture of Neurological Disorders

Figure 25. Product Picture of Others

Figure 26. Global Biobetter Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 27. Global Biobetter Sales Value Market Share by Application, 2023 & 2030

Figure 28. Global Biobetter Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 29. Global Biobetter Sales Volume Market Share by Application, 2023 & 2030

Figure 30. Global Biobetter Price by Application (2019-2030) & (US$/Unit)

Figure 31. North America Biobetter Sales Value (2019-2030) & (US$ Million)

Figure 32. North America Biobetter Sales Value by Country (%), 2023 VS 2030

Figure 33. Europe Biobetter Sales Value (2019-2030) & (US$ Million)

Figure 34. Europe Biobetter Sales Value by Country (%), 2023 VS 2030

Figure 35. Asia Pacific Biobetter Sales Value (2019-2030) & (US$ Million)

Figure 36. Asia Pacific Biobetter Sales Value by Country (%), 2023 VS 2030

Figure 37. South America Biobetter Sales Value (2019-2030) & (US$ Million)

Figure 38. South America Biobetter Sales Value by Country (%), 2023 VS 2030

Figure 39. Middle East & Africa Biobetter Sales Value (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa Biobetter Sales Value by Country (%), 2023 VS 2030

Figure 41. Key Countries/Regions Biobetter Sales Value (%), (2019-2030)

Figure 42. Key Countries/Regions Biobetter Sales Volume (%), (2019-2030)

Figure 43. United States Biobetter Sales Value, (2019-2030) & (US$ Million)

Figure 44. United States Biobetter Sales Value by Type (%), 2023 VS 2030

Figure 45. United States Biobetter Sales Value by Application (%), 2023 VS 2030

Figure 46. Europe Biobetter Sales Value, (2019-2030) & (US$ Million)

Figure 47. Europe Biobetter Sales Value by Type (%), 2023 VS 2030

Figure 48. Europe Biobetter Sales Value by Application (%), 2023 VS 2030

Figure 49. China Biobetter Sales Value, (2019-2030) & (US$ Million)

Figure 50. China Biobetter Sales Value by Type (%), 2023 VS 2030

Figure 51. China Biobetter Sales Value by Application (%), 2023 VS 2030

Figure 52. Japan Biobetter Sales Value, (2019-2030) & (US$ Million)

Figure 53. Japan Biobetter Sales Value by Type (%), 2023 VS 2030

Figure 54. Japan Biobetter Sales Value by Application (%), 2023 VS 2030

Figure 55. South Korea Biobetter Sales Value, (2019-2030) & (US$ Million)

Figure 56. South Korea Biobetter Sales Value by Type (%), 2023 VS 2030

Figure 57. South Korea Biobetter Sales Value by Application (%), 2023 VS 2030

Figure 58. Southeast Asia Biobetter Sales Value, (2019-2030) & (US$ Million)

Figure 59. Southeast Asia Biobetter Sales Value by Type (%), 2023 VS 2030

Figure 60. Southeast Asia Biobetter Sales Value by Application (%), 2023 VS 2030

Figure 61. India Biobetter Sales Value, (2019-2030) & (US$ Million)

Figure 62. India Biobetter Sales Value by Type (%), 2023 VS 2030

Figure 63. India Biobetter Sales Value by Application (%), 2023 VS 2030

Figure 64. Biobetter Industrial Chain

Figure 65. Biobetter Manufacturing Cost Structure

Figure 66. Channels of Distribution (Direct Sales, and Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-38B2538

Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Rheumatoid Arthritis Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-5A13262

Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Psoriasis Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-28R2574

Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Global Pharmaceutical Rubber Stopper Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-15W7068

Sat Oct 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Biobetter - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-6O13504

Biobetter - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Biobetter - Market Size

Biobetter - Market

Report Scope

Scope of Biobetter - Market Report

Chapter Outline

FAQ for this report

What is the Biobetter - Market size in 2030?

Who are the main players in the Biobetter - Market report?

What are the Application segmentation covered in the Biobetter - Market report?

What are the Type segmentation covered in the Biobetter - Market report?

FEATURED COMPANIES

RELATED REPORTS